BAK

Braskem S.A.

46
Fundamentals48/ 100
Valuation50/ 100
Upside potential64/ 100
Risk potential43/ 100

BAK lost money over the past year, so it has no meaningful PE right now.

BAK Fundamentals

MetricStatus
Stable
Stable
Weak
Weak

BAK's revenue and profitability are currently stable, but its cash flow and balance sheet are weak.

BAK PE Valuation

BAK has no meaningful PE right now: it lost money over the past year.

BAK Forward outlook

There aren't enough analyst estimates for BAK to show an outlook.

BAK Risk to reward

ScenarioChangePrice
Upside+77%$2.00
Downside-43%$0.64

Calculated from the latest close: $1.13 on Nov 12.

BAK's one-year upside scenario is about twice its downside: +77% against −43%.

BAK Earnings Per Share

Q3 2023: $-2.12Q4 2023: $-2.06Q1 2024: $-2.75Q2 2024: $-4.08Q3 2024: $-3.26Q4 2024: $-5.09Q1 2025: $-4.17Q2 2025: $-2.61Q3 2025: $-2.35Q4 2025: $-4.50Q1 2026: $-4.17Q2 2026: $-2.55
Q3 2023: $-2.12Q4 2023: $-2.06Q1 2024: $-2.75Q2 2024: $-4.08Q3 2024: $-3.26Q4 2024: $-5.09Q1 2025: $-4.17Q2 2025: $-2.61Q3 2025: $-2.35Q4 2025: $-4.50Q1 2026: $-4.17Q2 2026: $-2.55
QuarterTTM EPSYoY
Q2 2026-$2.55+$0.06
Q1 2026-$4.17$0.00
Q4 2025-$4.50+$0.59
Q3 2025-$2.35+$0.91
Q2 2025-$2.61+$1.47
Q1 2025-$4.17-$1.42
Q4 2024-$5.09-$3.03
Q3 2024-$3.26-$1.14

BAK is still losing money, but less than at its worst: $2.55 per share over the past year, against $5.09 at its worst in late 2024.

BAK Quarterly Revenue

Q3 2023: $3BQ4 2023: $3BQ1 2024: $3.2BQ2 2024: $3.4BQ3 2024: $3.8BQ4 2024: $3.4BQ1 2025: $3.5BQ2 2025: $3.2BQ3 2025: $3.1BQ4 2025: $2.9BQ1 2026: $2.8BQ2 2026: $3.9B
Q3 2023: $3BQ4 2023: $3BQ1 2024: $3.2BQ2 2024: $3.4BQ3 2024: $3.8BQ4 2024: $3.4BQ1 2025: $3.5BQ2 2025: $3.2BQ3 2025: $3.1BQ4 2025: $2.9BQ1 2026: $2.8BQ2 2026: $3.9B
QuarterRevenueYoY
Q2 2026$3.9B+22%
Q1 2026$2.8B-20%
Q4 2025$2.9B-16%
Q3 2025$3.1B-19%
Q2 2025$3.2B-6.4%
Q1 2025$3.5B+8.6%
Q4 2024$3.4B+15%
Q3 2024$3.8B+28%

BAK's revenue is recovering but still below its 2021 peak: $3.9B last quarter, up 22% from the same quarter a year ago.

BAK Free Cash Flow

Q3 2023: −$660MQ4 2023: −$39MQ1 2024: $17MQ2 2024: $76MQ3 2024: −$292MQ4 2024: −$38MQ1 2025: −$534MQ2 2025: −$167MQ3 2025: −$349MQ4 2025: −$266MQ1 2026: −$865MQ2 2026: −$96M
Q3 2023: −$660MQ4 2023: −$39MQ1 2024: $17MQ2 2024: $76MQ3 2024: −$292MQ4 2024: −$38MQ1 2025: −$534MQ2 2025: −$167MQ3 2025: −$349MQ4 2025: −$266MQ1 2026: −$865MQ2 2026: −$96M
QuarterFree cash flowYoY
Q2 2026-$95.8M+$71.3M
Q1 2026-$864.9M-$330.5M
Q4 2025-$265.7M-$227.2M
Q3 2025-$349.3M-$57.5M
Q2 2025-$167M-320%
Q1 2025-$534.4M-3242%
Q4 2024-$38.5M+$895.2K
Q3 2024-$291.8M+$368.5M

BAK has burned cash in eight of the last eight quarters: −$1.6B over the past year, against −$1B the year before.

BAK Total Shares

Q3 2023: 399MQ4 2023: 399MQ1 2024: 399MQ2 2024: 399MQ3 2024: 398MQ4 2024: 398MQ1 2025: 398MQ2 2025: 398MQ3 2025: 398MQ4 2025: 399MQ1 2026: 399MQ2 2026: 398M
Q3 2023: 399MQ4 2023: 399MQ1 2024: 399MQ2 2024: 399MQ3 2024: 398MQ4 2024: 398MQ1 2025: 398MQ2 2025: 398MQ3 2025: 398MQ4 2025: 399MQ1 2026: 399MQ2 2026: 398M
PeriodChange %Net change
Quarterly-0.1%-328K shares
1 year-0.1%-208K shares
3 years0%-45.6K shares
5 years+0.1%+276K shares
Available history+0.1%+405K shares

BAK has 398M diluted shares, about the same as a year ago.

BAK Net Leverage

Q3 2023: 3.0xQ4 2023: 17.1xQ1 2024: 78.8xQ1 2025: 2,506.9xQ2 2025: 9.5xQ3 2025: 16.9xQ4 2025: 9.8xQ1 2026: 9.7xQ2 2026: 6.9x
Q3 2023: 3.0xQ4 2023: 17.1xQ1 2024: 78.8xQ1 2025: 2,506.9xQ2 2025: 9.5xQ3 2025: 16.9xQ4 2025: 9.8xQ1 2026: 9.7xQ2 2026: 6.9x
QuarterNet LeverageStatus
Q2 20266.9xHigh
Q1 20269.7xHigh
Q4 20259.8xHigh
Q3 202516.9xHigh
Q2 20259.5xHigh
Q1 20252,506.9xHigh
Q1 202478.8xHigh
Q4 202317.1xHigh

BAK's net debt is about 6.9 years of its operating earnings (EBITDA), down from 9.4 years a year ago.

BAK Weekly Momentum

MetricValueStatus
RSI32.3Neutral
Stochastic20.1Neutral

BAK's weekly RSI is 32 (neutral) and its Stochastic is 20 (neutral).

BAK PE vs Basic Materials Sector

BAK has no meaningful PE right now: it lost money over the past year.

BAK Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$1.4623% below
20 week MA$1.8840% below
50 week MA$2.9161% below
100 week MA$3.1965% below
200 week MA$5.5780% below

BAK is in a downtrend: it's below all five of its weekly moving averages, and 80% below its 200-week average.

BAK Yearly ROI

YearStart priceEnd priceROI
2020$15.0$8.86-41%
2021$8.86$20.1+127%
2022$20.1$9.29-54%
2023$9.29$8.82-5.1%
2024$8.82$3.80-57%
2025$3.80$2.93-23%
2026 YTD$2.93$1.13-61%

BAK has finished four years in a row lower, and it's down 61% so far in 2026.

Give your agent the market.

Get API key